REVIEW
Accepted on 23 Jun 2025
CXCR3 inhibitors for Therapeutic Interventions: Current status and perspectives
doi 10.3389/fphar.2025.1556196
- 182 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Reviews in Pharmacology of Anti-Cancer Drugs: 2023
Reviews in Pharmacology of Anti-Cancer Drugs: 2023
5,146
Total downloads
20k
Total views and downloads
Articles
REVIEW
Published on 10 Feb 2025
A comprehensive review of Schisandrin B’s preclinical antitumor activity and mechanistic insights from network pharmacology
doi 10.3389/fphar.2025.1528533
- 1,200 views
ORIGINAL RESEARCH
Published on 05 Feb 2025
A pharmacoinformatic approach for studying Atractylodes Lancea DC’s anticancer potential and control ROS-mediated apoptosis against prostate cancer cells
doi 10.3389/fonc.2025.1471110
- 2,180 views
REVIEW
Published on 04 Feb 2025
A review on intrathecal administration of medications for leptomeningeal metastases in solid tumors
doi 10.3389/fphar.2025.1472945
- 2,469 views
REVIEW
Published on 04 Dec 2024
Recent advances in cell membrane-coated porphyrin-based nanoscale MOFs for enhanced photodynamic therapy
doi 10.3389/fphar.2024.1505212
- 1,198 views
- 5 citations
REVIEW
Published on 09 Oct 2024
From defense to offense: antimicrobial peptides as promising therapeutics for cancer
doi 10.3389/fonc.2024.1463088
- 2,849 views
- 6 citations
REVIEW
Published on 01 Oct 2024
RGD-based self-assembling nanodrugs for improved tumor therapy
doi 10.3389/fphar.2024.1477409
- 2,038 views
- 3 citations
REVIEW
Published on 27 Sep 2024
Diversified applications of hepatocellular carcinoma medications: molecular-targeted, immunotherapeutic, and combined approaches
doi 10.3389/fphar.2024.1422033
- 1,244 views
- 1 citation
ORIGINAL RESEARCH
Published on 26 Jul 2024
A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases
doi 10.3389/fphar.2024.1374136
- 1,503 views
- 1 citation
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore